Navigation Links
Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older
Date:12/22/2010

ducts. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at www.pfizer.com.

DISCLOSURE NOTICE: The information contained in this release is as of December 22, 2010. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

This release contains forward-looking information that involves substantial risks and uncertainties regarding a potential indication for Prevnar 13 for use in adults in various markets, including the U.S. and the EU, and the potential benefits of Prevnar 13. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory applications will be submitted in various markets other than the U.S. and the EU for a potential indication for Prevnar 13 for use in adults; whether and when the FDA, the EMA and regulatory authorities in other jurisdictions will approve applications that have been or may be submitted for this potential indication and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.  

A further description of risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2009
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
2. Pfizer Board of Directors Elects George A. Lorch Non-Executive Chairman
3. Pfizer Declares A 20-Cent First-Quarter 2011 Dividend
4. Young Children In Developing World Receive Accelerated Access to Pfizers Prevenar 13 Vaccine
5. Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
6. Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia
7. Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)
8. Pfizer Launches New Advil® Congestion Relief and Offers 100 Holiday Shoppers Literal Decongestion From Black Friday Crowds
9. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
10. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
11. Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... ENDO 2013, the Endocrine Society,s 95 th ... both melatonin and cortisol rhythms. This effect further ... clock and address the circadian desynchrony which is ... and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study ...
(Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...
(Date:6/17/2013)... June 17, 2013 The following is a Statement ... at Drugfree.org :   Last Friday, ... was halting the sale of prescription drug paraphernalia products. The ... that from time to time there may be individual items ... As a result of this misinterpretation we are electing to ...
Breaking Medicine Technology:Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4A Win for Families: Urban Outfitters Halts Prescription Drug Paraphernalia Product Sales 2
... it has been selected as a Finalist ... list honoring the year,s most promising private technology ventures ... The Red Herring editorial team selected the most innovative ... America. The nominees are evaluated on both quantitative and ...
... a full-service pharmacy benefit management and ancillary medical ... Craig Rollins has joined the organization as Vice ... role he will be responsible for the strategic ... 1Click Ancillary online marketplace. myMatrixx launched 1Click Ancillary ...
Cached Medicine Technology:DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award 2myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development 2
(Date:6/17/2013)... NY (PRWEB) June 17, 2013 The Woodstock ... Blake to attend the Festival this summer, which will be ... through Sunday, August 25th. , Blake professes the benefits ... a day to fuel his world class sprinting abilities. ... volume of fruit is drawing attention. "Yohan Blake believes in ...
(Date:6/17/2013)... City Beach, FL (PRWEB) June 17, 2013 ... higher purpose--fighting hunger. Oceana Naturals LLC, the US distributor ... region of The Bay Area Food Bank ... families, and struggling seniors by seeing that they receive ... Natural Sunscreen and All Natural Moisturizer. Contributions will ...
(Date:6/17/2013)... (June 17, 2013) A team from the New ... Naomi Berrie Diabetes Center of Columbia University has generated ... the features of maturity-onset diabetes of the young (MODY). ... patients to produce induced pluripotent stem (iPS) cells, from ... mouse, the stem cell-derived beta cells secreted insulin in ...
(Date:6/17/2013)... Keller, TX (PRWEB) June 17, 2013 Tarrant ... special. , The term ‘mommy makeover’ has recently undergone ... from surgeon to surgeon. At Tarrant Plastic Surgery, they regard ... procedures designed to remove and reverse many of the effects ... the breast may typically include: drooping of the breast with ...
(Date:6/17/2013)... new drug called pyrvinium pamoate inhibits aggressive forms of ... to a study conducted in an animal model. The ... 95th Annual Meeting in San Francisco. , "Our novel ... action," said study lead author Jeremy Jones, PhD, assistant ... Research Institute, in Duarte, CA. "Thus, it has the ...
Breaking Medicine News(10 mins):Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:All Natural Sunscreen Fights Hunger 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2Health News:New medication treats drug-resistant prostate cancer in the laboratory 2
... Delhi is planning to interlink its major 29 hospitals ... and treatment provided. This computerization and interlinking of data ... by which doctors can know the case history and ... modules of software to deal with different hospital departments. ...
... number of psychiatric disorders, including mood disorders, schizophrenia// ... shown to increase the risk for emergence of ... disorder), and that presence of certain anxiety disorders ... development of nicotine dependence. ,A recent study ...
... or growing fast: systematic review of size and growth ... who grow rapidly during the first two years of life, ... a study reveals. ,There is an urgent need to ... is not clear how early in life prevention could begin. ...
... is no link whatsoever between breast cancer and cholesterol levels ... control the same. ,The details of the study ... Internal Medicine, one of the JAMA/Archives journals. The article says ... to suggest that the statins may work in conjunction with ...
... compulsory licensing (CL) provision in the Patents Act that ... Swiss drug maker Roche’s patented drug Tamiflu, useful in ... flu virus. , ,Section 92 empowers the government ... the industry. Furthermore, the issue of such license is ...
... a large, heterogeneous group of rare pulmonary disorders ... abnormal gas exchange with considerable mortality and morbidity. ... diagnosis includes more than 100 conditions in both ... and Colorado conducted a descriptive, observational study was ...
Cached Medicine News:Health News:Delhi Government To Interlink All Major Hospitals Through e-Governance 2Health News:Smokers Are Prone To Number Of Psychiatric Disorders 2Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2
Full Handle Laseredge Implant Blade Knife, 5.2 mm straight. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, angled double bevel. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Crescent Blade Knife, angled bevel up. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: